Skip to content
Open access · CC-BY via OpenAlex

Nicotinamide Riboside—The Current State of Research and Therapeutic Uses

Mario Mehmel, Nina Dimitrijević Jovanović, Urs P. Spitz

Nutrients · 2020 · ▲ 222 citations

Abstract

Nicotinamide riboside (NR) has recently become one of the most studied nicotinamide adenine dinucleotide (NAD+) precursors, due to its numerous potential health benefits mediated via elevated NAD+ content in the body. NAD+ is an essential coenzyme that plays important roles in various metabolic pathways and increasing its overall content has been confirmed as a valuable strategy for treating a wide variety of pathophysiological conditions. Accumulating evidence on NRs’ health benefits has validated its efficiency across numerous animal and human studies for the treatment of a number of cardiovascular, neurodegenerative, and metabolic disorders. As the prevalence and morbidity of these conditions increases in modern society, the great necessity has arisen for a rapid translation of NR to therapeutic use and further establishment of its availability as a nutritional supplement. Here, we summarize currently available data on NR effects on metabolism, and several neurodegenerative and cardiovascular disorders, through to its application as a treatment for specific pathophysiological conditions. In addition, we have reviewed newly published research on the application of NR as a potential therapy against infections with several pathogens, including SARS-CoV-2. Additionally, to support rapid NR translation to therapeutics, the challenges related to its bioavailability and safety are addressed, together with the advantages of NR to other NAD+ precursors.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/nu12061616
Canonical
link ↗
Fetched
2026-10-09 MST

Cite this

APA
Mehmel, M., Jovanović, N.D., &amp; Spitz, U.P. (2020). Nicotinamide Riboside—The Current State of Research and Therapeutic Uses. <em>Nutrients</em>. https://doi.org/10.3390/nu12061616
Vancouver
Mehmel M, Jovanović ND, Spitz UP. Nicotinamide Riboside—The Current State of Research and Therapeutic Uses. Nutrients. 2020. doi:10.3390/nu12061616.
BibTeX
@article{mario2020Nicoti, title = {Nicotinamide Riboside—The Current State of Research and Therapeutic Uses}, author = {Mario Mehmel and Nina Dimitrijević Jovanović and Urs P. Spitz}, journal = {Nutrients}, year = {2020}, doi = {10.3390/nu12061616}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings